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 Chronic Kidney Disease (CKD) is a major public 
health issue with the prevalence continuing to 
escalate, in part due to increasing diabetes and 
hypertension.1 In patients undergoing coronary 
revascularization for either stable coronary artery 
disease or acute myocardial infarction, CKD is one 
of the strongest risk factors for short- and long-
term mortality.2 Mortality, myocardial infarction 
(MI), repeat revascularization, and bleeding 
complication rates are all increased after coronary 
revascularization compared with that of patients 
with normal renal function.3 CKD is an independent 
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Mode of coronary revascularization and short term clinical 
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ABSTRACT
Background and Objective: Percutaneous coronary intervention (PCI) and coronary artery bypass graft 
(CABG) surgery are two alternative methods for coronary revascularization, but it remains controversial 
as which one is associated with lower risks of worse clinical outcomes for chronic kidney disease (CKD) 
patients. We determined the mode of coronary revascularization (PCI vs. CABG) which is associated with 
lower risk of mortality and morbidity in CKD patients.
Methods: In this cross sectional study, 159 patients with CKD were enrolled from single center of coronary 
revascularization at Aga Khan University Hospital Karachi between January 2012 and August 2013. All 
patients with CKD underwent PCI or CABG. The primary outcome was in-hospital composite of death, 
myocardial infarction (MI), or stroke. We evaluated which mode of coronary revascularization was 
associated with reduced risks of clinical outcomes.
Results: Out of 159 patients with CKD, 85 (53.5%) received PCI and 74 (46.5%) received CABG. The primary 
finding	of	this	study	is	that	more	patients	with	moderate	to	severe	CKD	underwent	PCI	and	more	patients	
with mild to moderate CKD underwent CABG. In both these categories, no difference was observed in 
clinical outcomes. There are few factors like age, ST- elevation myocardial infarction (STEMI), non-ST 
elevation myocardial infarction (NSTEMI) and number of coronary artery disease predicted PCI as treatment 
strategy in patients with moderate to severe CKD.
Conclusion: Patients with moderate to severe CKD have similar rates of short term clinical outcomes 
whether they underwent PCI or CABG. Therefore, PCI can be acceptable and less invasive treatment option 
alternative to CABG, particularly in patients with moderate to severe CKD.
KEY WORDS: Chronic kidney disease, Creatinine clearance, Coronary revascularization, Percutaneous 
coronary intervention, Coronary artery bypass graft.
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predictor of incident stroke, myocardial infarction 
(MI), and all-cause mortality.4 
 There is evidence that coronary revascularization 
reduces the cardiac mortality and improves 
prognosis compared to medical treatment for CKD 
patients with CAD.5 With regard to evidence of best 
mode of coronary revascularization, percutaneous 
coronary intervention (PCI) and coronary artery 
bypass grafting (CABG) are two alternative 
methods, but it remains controversial as which 
one is associated with reduced major adverse 
cardiac and cerebral events (MACCE), reduced 
risk of worsening kidney function and need of 
hemodialysis and reduced in-hospital stay for CKD 
patients.
 Previous studies suggested that CKD is associated 
with increased mortality after CABG6 perhaps 
because such patients have longer postoperative 
mechanical ventilation time, higher postoperative 
bleeding rates and transfusion requirements, and 
increased length of hospital stay. PCI in patients 
with CKD is also high-risk due to their increased 
incidence of worsening kidney function, restenosis, 
and mortality.7 The increased risk occurs even with 
mild renal insufficiency; with a doubling of mortality 
at one year.8 To the best of our knowledge, there 
is paucity of prospective study results on clinical 
outcomes of CKD in patients undergoing coronary 
revascularization as well as optimal strategy for 
coronary revascularization which is associated 
with lower risks of cardiovascular mortality and 
morbidity in resource constraint countries of South-
Asian region particularly Pakistan.
 The aim of this study was to determine the mode 
of coronary revascularization (PCI vs. CABG) in 
CKD patients, which is associated with less major 
adverse cardiac cerebral events (MACCE) and 
lower risk of worsening kidney function and need 
of hemodialysis and minimum in-hospital stay.
METHODS
 In this cross sectional study, 159 patients with 
CKD were enrolled from single center of coronary 
revascularization at Aga Khan University Hospital 
Karachi between January 2012 and August 2013. The 
mode of revascularization included Percutaneous 
Coronary Intervention (PCI) [Patients were treated 
with one or more stents but excluding POBA (Plain 
Old Balloon Angioplasty)] and Coronary Bypass 
Grafting (CABG). Patients were excluded if there 
was severe anemia or liver disease. In total, 159 
patients with CKD formed the study sample (122 
men, 37 women and mean age 65±9.6 [range 38-88] 
years). Patients were stratified into three groups 
based on Creatinine Clearance (CrCl). Baseline 
demographics, clinical and angiographic features 
were recorded for each patient. This study was 
reviewed and approved by the institutional ethical 
review committee of Aga Khan University Hospital. 
All patients had serum creatinine measured 24-48 
hours before the revascularization. Renal function 
was assessed by the creatinine clearance (CrCl) 
estimated using the Cockcroft-Gault formula.9 
Patients with estimated creatinine clearance (CrCl) ≤ 
90 ml/min were defined as having Chronic Kidney 
Disease (CKD), consistent with CKD stage 2 of the 
National Kidney Foundation classification10 and 
these patients were classified into 3 CrCl groups: 
<30ml/min (n= 59), 30-59ml/min (n= 79) and 60-
89ml/min (n=21). All patients who underwent 
coronary revascularization (PCI or CABG) were 
observed during the hospital stay after the 
procedure. During the hospital stay, major adverse 
clinical outcomes (MACCE) including all-cause 
of death, new onset myocardial infarction, and 
stroke were recorded. Within the first 7 days after 
revascularization, MI was defined by appearance 
of new abnormal Q-wave (according to Minnesota 
Code11 plus a ratio of serum creatinine kinase MB 
(CK-MB) iso- enzyme to total cardiac enzyme >0.1 
or a Creatinine kinase MB elevated at least 3-fold the 
upper limit of the normal range. After 7 days of the 
revascularization, abnormal Q-waves or enzymatic 
changes were enough to diagnose MI.12 Stable 
angina was defined according to the system of the 
Canadian Cardiovascular Society (CCS).13 Unstable 
angina was defined according to the Braunwald 
classification.14 The number of diseased coronary 
vessels was defined as number of coronary arteries 
with luminal diameter narrowing ≥70% and the left 
main coronary artery stenosis ≥50% was considered 
to be 3-vessel coronary artery disease (3V-CAD). 
Left anterior descending (LAD) proximal lesion was 
defined as stenosis ≥70% in the proximal half of the 
LAD. Long lesion was defined as stenosis > 20mm. 
Ostial lesion was defined as stenosis within 3mm of 
the origin of the vessel. Complete revascularization 
was defined if there was no remaining stenosis 
≥70% in the coronary artery luminal diameter ≥ 
2mm.
 A descriptive analysis was performed for 
demographic and clinical characteristics and results 
are presented as mean ± standard deviation for 
quantitative variables and numbers (percentages) for 
qualitative variables. Participants with CKD treated 
with CABG and PCI with stenting were assessed by 
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using the Chi-square test or Fisher exact test where 
appropriate. For contrasts of continuous variables, 
Independent t-test was used to assess the difference 
of means. In univariate analysis, compared the 
association of PCI with clinical outcomes and 
other covariates. Logistic regression analysis was 
performed to assess factors that predict favorable 
outcome. Patients were stratified into three groups 
based on Creatinine Clearance (CrCl). Comparisons 
among groups were made by pearson chi-square 
test for categorical variables and ANOVA test for 
variance for continuous variables. All analyses 
were conducted by using the Statistical package for 
social science SPSS (Release 19.0, standard version, 
copyright © SPSS; 1989-02).  All p-values were two 
sided and considered as statistically significant if < 
0.05.
RESULTS
 In this study of 159 patients with CKD, (mean 
age 65±9.6 (38-88) years, 122 (76.7%) of them were 
male and the indication for revascularization were 
non-ST-elevation MI (69, 43.4%), ST-elevation 
MI (34, 21.4%), stable angina (31, 19.5%) and 
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Table-I: Characteristics of patients with CKD after PCI and CABG.
 Total (n=159) PCI (n=85) CABG (n=74) p value
Age (years)  67±9 63±9 0.003
Male 122(76.7%) 63 (74.1%) 59(79.7%) 0.45
Female 37 (23.3%) 22(25.9%) 15(20.3%) 
Hemoglobin 11.5 ± 1.76 11.4±1.8 11.6±1.6 0.66
WBC 11.1 ± 5.1 12.4±6.2 9.5±2.8 < 0.001
Baseline creainine(mg/dl) 2.3 ± 1.5 2.7±1.7 1.7±0.9 < 0.001
Creatinine on admission(mg/dl) 2.6 ± 2.0 3.4±2.3 1.8±1.04 < 0.001
Creatinine Clearance (ml/min)    
< 30 59(37.1%) 51(60%) 8(10.8%) <0.001
30-59 79(49.7%) 28(32.9%) 51(68.9%) 
60-89 21(13.2%) 6(7.1%) 15(20.3%) 
Current smoking history 159(100%) 5(5.9%) 13(17.6% 0.02
Hypertension 144(90.6%) 77(90.6%) 67(90.5%) 0.99
Diabetes mellitus 108(67.9%) 60(70.6%) 48(64.9%) 0.99
History of ischemic stroke 16(10.1%) 11(12.9%) 5(6.8%) 0.27
History of hemorrhagic stroke 1(0.6%) 0(0.0%) 1(1.4%) 0.36
Valvular heart disease 34(21.4%) 19(22.4%) 15(20.3%) 0.84
Prior MI 59(37.1%) 36(42.4%) 23(31.1%) 0.18
Prior kidney disease 157(98.7%) 85(100%) 72(97.3%) 0.21
with dialysis 25(15.7%) 21(24.7%) 4(5.4%) 0.001
without dialysis 134(84.3%) 64(75.3%) 70(94.6%) 0.001
Peripheral vascular disease 1(1.2%) 1(1.2%) 0(.0%) 0.99
Prior revascularization 40(25.2%) 31(36.5%) 9(12.2%) <0.001
LVEF <40% 77(48.4%) 41(48.2%) 36(49.3%) 0.99
Indications for revascularization    
Stable angina 31(19.5%) 5(5.9%) 26(35.1%) <0.001
Unstable angina 27(17%) 10(11.8%) 17(23%) 0.08
NSTEMI 69(43.4%) 44(51.8%) 25(33.8%) 0.02
STEMI 34(21.4%) 26(30.6%) 8(10.8%) 0.003
Number of diseased vessels    
1 25(15.7%) 23(27.1%) 2(2.7%) <0.001
2 45 (28.3%) 28(32.9%) 17(23.3%) <0.001
3 88(55.3%) 34(40%) 54(74%) < 0.001
Creatinine after 48 hours of procedure  2.9±1.7 3.2 ± 2.1 2.5 ± 0.9 0.004
Required Heamodialysis after procedure 159(100%)        12 (14.1%) 0 (0%) 0.001
Length of stay(days) 7.8 ± 6.8 5.4 ± 3.9 10.6 ± 6.9 < 0.001
MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft.
unstable angina (27, 17%). The mode of coronary 
revascularization was PCI (85, 53.5%) or CABG (74, 
46.5%).
 Baseline characteristics like hypertension, 
diabetes mellitus, current smoking history, history 
of ischemic or hemorrhagic stroke, valvular 
heart disease, prior MI, prior revascularization, 
left ventricular ejection fraction (LVEF<40%) 
and indications for revascularization were not 
significantly different among 3 groups of CKD. 
All three groups of CKD had multivessel coronary 
artery disease. Almost one third of patients in severe 
CKD group (33.9%) were on long term hemodialysis 
before the revascularization, whereas only few 
number of patients, 2 (9.5%) and 3 (3.8%) in the mild 
and moderate CKD groups respectively were on 
long term hemodialysis before revascularization. 
 The evidence of left main lesion, LAD proximal 
lesion, ostial lesion, chronic total occlusion, in-
stent restenosis, long lesion or complex lesion was 
almost similar among the 3 groups of CKD. In the 
severe CKD group, more patients underwent PCI 
whereas, in the mild to moderate groups of CKD, 
more patients underwent CABG. Though the rate of 
failed PCI was similar among the 3 groups of CKD 
but complete revascularization was more evident 
in mild to moderate CKD. The baseline creatinine 
(p<0.001) and creatinine on admission (p<0.001) 
were higher in the PCI group compared to CABG 
group (2.7±1.7), (3.4±2.3) and (1.7±0.9), (1.8±1.04) 
respectively. More importantly, the choice of mode 
of revascularization among moderate to severe 
CKD group (CrCl 30-59 ml/min and CrCl <30ml/
min) was PCI as compared to CABG which was 
mode of revascularization in mild to moderate CKD 
group (CrCl 30-59 ml/min and CrCl 60-89ml/min). 
More patients with CKD already on hemodialysis 
were in the PCI group as compared to CABG group 
21 (24.7%) and 4 (5.4%) with p value of 0.001.
 In terms of indications of revascularization, 
CABG was treatment of choice in patients with 
stable angina whereas PCI was the choice of 
mode of revascularization in STEMI and NSTEMI. 
Serum creatinine after 48 hours of procedure was 
higher in PCI group as compared to CABG group 
(3.2 ± 2.1 and 2.5 ± 0.9) respectively. Along with 
this, 12 (14.1%) patients in the moderate to severe 
CKD group underwent hemodialysis and CRRT 
(continuous renal replacement therapy) after the 
procedure and all of them were in the PCI group; 
6 of them were already on hemodialysis prior to 
procedure. In-hospital stay was 5.4 ± 3.9 and 10.6 
± 6.9 days with p<0.001 for PCI and CABG group 
respectively (Table-I). There was no difference in the 
frequency of the individual short term outcomes of 
stroke, MI, or death between treatment groups PCI 
vs. CABG (Table-II). There are few factors like age, 
STEMI,NSTEMI, prior revascularization, complete 
revascularization and number of coronary artery 
disease which predicted PCI as treatment strategy 
in patients with moderate to severe CKD (Table-III).
DISCUSSION
 The primary finding of this observational study 
is that more patients with moderate to severe 
CKD underwent PCI and more patients with mild 
to moderate CKD underwent CABG. In both of 
these categories, clinical outcomes were similar. 
In the recent meta-analysis done by Chen YY and 
his colleagues, high heterogeneity in short term 
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Table-II: Clinical outcomes among patients with CKD after PCI or CABG.
 PCI CABG OR (95% CI) p value
MACCE 18 (21.2%) 14 (18.9%) 1.15[0.52-2.51] 0.72
Death 10 (11.8%) 8(10.8%) 1.10[0.41-2.95] 0.85
Cardiogenic 2(2.4%) 3(4.1%) 1.31[0.21-8.10] 0.76
Non cardiogenic 8(9.4%) 5(6.8%) 1.43[0.44-4.59] 0.54
MI 9 (10.6%) 8 (10.8%) 0.97[0.35-2.67] 0.96
Stroke 1(1.2%) 2(2.7%) 2.33[0.20-26.26] 0.49
OR, odds ratio; CI, confidence interval; MACCE, major adverse cardiac cerebral events.
Other abbreviations see Table-I.
Table-III: Multivariate analysis of factors 
predicting PCI among CKD patients.
 OR (95% CI) p value
Age 1.06 (1.001-1.14)   0.04
NSTEMI 18 (3.22-100)   0.001
STEMI 8.54 (1.46-50)   0.01
Prior revascularization 21 (3.59-119.2)   0.001
Complete revascularization 0.004 (0-0.04) <0.001
Number of disease vessels  
2 0.03(0.005-0.25)   0.001
3 0.005 (0.001-0.04) <0.001
OR, odds ratio; CI, confidence interval; 
Other abbreviations see Table-I.
mortality was found among the studies included 
in the meat analysis. Chen YY states in his study 
that worse kidney function in the beginning was 
associated with worse post-procedure outcomes, 
but PCI still had reduced short term mortality as 
compared to CABG in dialysis dependent patients.15 
Interestingly, this finding in our study is opposite 
to study done by Zhang Q et al. who had shown 
that patients with lowest CrCl underwent CABG 
while patients with normal creatinine or mild renal 
insufficiency underwent PCI.16
 Similar findings were present in the study done by 
Ix JH et al in which he had shown that participants 
with mild to moderate CKD undergoing coronary 
revascularization had similar rates of MI, stroke, 
or death whether they underwent PCI with 
multivessel stenting or CABG.17 The observational 
studies done in the past showed conflicting results 
about the implications of CKD on clinical outcomes 
after coronary revascularization. Szczech et al. 
found the adjusted estimated 2-year survival to be 
51.9% after PCI and 77.4% after CABG in patients 
with renal insufficiency.18 In the study with greater 
utilization of stents in PCI patients, Reddan et al. 
found a survival advantage with CABG compared 
with PCI which appeared to increase as renal 
function declined.19 In contrast to these studies, PCI 
provided survival benefit in comparison to medical 
management in patients with mild to moderate 
renal insufficiency.19 Nevertheless, Rubenstein 
et al found more promising short- and long-
term outcomes using advances in interventional 
cardiology such as stents and debulking devices.20 
In retrospective study of 1,654 patients with a 
glomerular filtration rate of <60ml/min revealed 
that PCI yielded better results than medical therapy 
and CABG in renal insufficiency patients with acute 
coronary syndromes.21
 Another important point in our study is that 
patients with mild and moderate CKD received 
CABG while patients with moderate to severe CKD 
received PCI, this might indicate the selection bias 
on part of operator. It means patients with severe 
kidney disease and acute coronary syndromes are 
undergoing PCI. Our study has also shown that 
patients who were undergoing PCI were older and 
they had higher baseline and admission serum 
creatinine. Therefore there were few factors like 
age, STEMI, NSTEMI, and number of coronary 
artery disease which predicted PCI as treatment 
strategy in patients with moderate to severe CKD. 
But in our study short term clinical outcomes are 
not different among two treatment groups. Because 
worse kidney function in the beginning was 
associated with worse post-procedure outcomes. 
These equivalent rates of stroke, new-onset MI, or 
cardiogenic and non-cardiogenic death between 
two treatment groups among patients with CKD 
indicate that PCI can be acceptable and less invasive 
treatment option alternative to CABG, particularly 
in patients with moderate to severe CKD. 
Despite the new advancements in interventional 
cardiology, including drug eluting stents(DES) and 
bioabsoable stents, distal protection devices, and 
use of newer antithrombotic agents and marked 
progress in CABG in terms of on-pump CABG, 
optimal treatment strategy in patients with CKD 
undergoing coronary revascularization is still 
debatable. The primary limitation of this study is 
that it was not randomized study and it had shown 
only short term clinical outcomes. It also had 
relied on estimated creatinine clearance calculated 
through the Cockcroft-Gault formula, which is an 
imprecise measure of kidney function.
CONCLUSION
 The present study is perhaps the first of its kind 
in this part of South-Asian region to prospectively 
evaluate mode of coronary revascularization 
and the clinical outcomes in patients with CKD. 
Our results have demonstrated that patients with 
moderate to severe CKD have similar rates of short 
term clinical outcomes whether they underwent 
PCI or CABG. Our results also confirm that CKD 
is a significant risk factor for patients undergoing 
coronary revascularization. PCI can be acceptable 
and less invasive treatment option alternative to 
CABG. Further randomized controlled trials with 
longer follow up are required to establish the 
optimal strategy for coronary revascularization in 
patients with CKD in this part of the world.
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